See All Slides - tctmd.com

Slides

Presentation THT 2025

Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies

Presenter: Gregg Stone

February 13, 2025

Presentation THT 2025

The PercAssist Percutaneous Synchronized Cardiac Assist (PSCA) System: Addressing the #1 Cause of Death After a Heart Attack by Reinventing the Standard of Care in Mechanical Circulatory Support

Presenter: Gerardo Noriega

February 13, 2025

Presentation THT 2025

Implantable Cardiac Patch Continuously Monitors Inflammation and Acute Heart Failure Biomarkers In Vivo and Ex Vivo

Presenter: Devleena Das

February 13, 2025

Presentation THT 2025

Continuous Molecular Monitoring for Precision Heart Failure Care

Presenter: Alex Yoshikawa

February 13, 2025

Presentation THT 2025

Real-World Survival Comparison of Symptomatic Patients With Heart Failure Treated With Cardiac Contractility Modulation (CCM) vs. Cardiac Resynchronization Therapy (CRT)

Presenter: Andrew Sauer

February 13, 2025

Presentation THT 2025

Use of AI for Improved HF Event Detection and Automated Drug Titration in Patients With and RPM Deice Planning for the Future: Perspective 2

Presenter: Kartik Sundareswaran

February 13, 2025

Presentation THT 2025

reBEAT: Biventricular Epicardial Augmentation Technology for HF Patients: Introducing a Novel MCS Technology, First-in-Human Translational Insights, Strategy for Pivotal Trial and Market Entry

Presenter: Stephen Wildhirt

February 13, 2025

Presentation THT 2025

PICS: A Novel Temporary CV Support Device Augmenting BP and Flow

Presenter: Alex Rothman

February 13, 2025

Presentation THT 2025

How Helpful Can EFIC Be in the US?

Presenter: Graham Nichol

February 13, 2025

Presentation THT 2025

Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies

Presenter: David Cohen

February 13, 2025

Advertisement

Slides

Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies

The PercAssist Percutaneous Synchronized Cardiac Assist (PSCA) System: Addressing the #1 Cause of Death After a Heart Attack by Reinventing the Standard of Care in Mechanical Circulatory Support

Implantable Cardiac Patch Continuously Monitors Inflammation and Acute Heart Failure Biomarkers In Vivo and Ex Vivo

Continuous Molecular Monitoring for Precision Heart Failure Care

Real-World Survival Comparison of Symptomatic Patients With Heart Failure Treated With Cardiac Contractility Modulation (CCM) vs. Cardiac Resynchronization Therapy (CRT)

Use of AI for Improved HF Event Detection and Automated Drug Titration in Patients With and RPM Deice Planning for the Future: Perspective 2

reBEAT: Biventricular Epicardial Augmentation Technology for HF Patients: Introducing a Novel MCS Technology, First-in-Human Translational Insights, Strategy for Pivotal Trial and Market Entry

PICS: A Novel Temporary CV Support Device Augmenting BP and Flow

How Helpful Can EFIC Be in the US?

Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content